BioCentury
ARTICLE | Company News

University of Rochester, Vivione deal

July 20, 2015 7:00 AM UTC

The university granted Vivione an option for exclusive, worldwide rights to neutrophilic integrin alpha(3) ( VLA-3; CD49C) biomarker used in the diagnosis of infectious diseases and a related anti-V...